In response to the national supply shortage of prescribed medication for ADHD, a GM task and finish group led the development of the following supporting guidance:

  • National Supply Shortage of prescribed medication for ADHD – A Guide for Secondary Care
  • GM Pathway for the management of patients prescribed medicines for ADHD during the national shortage – primary care guidance
  • Patient information – “National Supply Shortage of your prescribed medication for ADHD”

This guidance is now available below.

Document Title Issue Date Review Date Status
Primary care: Pathway for the Management of Patients Prescribed Medicines for ADHD during the National Shortage 20231124 Nov 2023
Addendum to GM pathway for primary care ADHD medicines shortages 20240224 Feb 2024
Primary care letter template: to inform patients of a switch from a branded generic methylphenidate MR tablet preparation to an alternative 20231124 Nov 2023
Secondary care: National supply shortage of prescribed medication for ADHD 20231124 Nov 2023
Patient information leaflet: National Supply Shortage of your prescribed medication for ADHD 20231124 Nov 2023